4.5 Article

A theoretical mathematical assessment of the effectiveness of coartemether in the treatment of Plasmodium falciparum malaria infection

Journal

MATHEMATICAL BIOSCIENCES
Volume 256, Issue -, Pages 28-41

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.mbs.2014.07.010

Keywords

Malaria; Effectiveness of drugs; Mathematical modeling; Coartem; Numerical analysis

Funding

  1. National Institute for Mathematical and Biological Synthesis (NIMBioS)
  2. National Science Foundation (NSF) [EF-0832858]
  3. University of Tennessee
  4. Direct For Biological Sciences
  5. Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation

Ask authors/readers for more resources

This study analysed the dynamics of blood stage malaria with immune response and under administration of Coartem as a combination therapy. The techniques of mathematical modelling were used in coming up and analysing the deterministic model. Sensitivity analysis and statistical approaches were used to compare model simulated treatment results with the use of Coartem and other antimalarial drugs. We sought to theoretically assess if Coartem can bring improvement in the treatment of malaria as compared to the other drugs. Our analysis and numerical results suggest that Coartem compares well with other antimalarial drug that have been on the market. However, the shortfall of our model is that it could not give good comparative results between Coartem treatment and other combination treatment schemes with similar mode of action. Our study predicted effects of different drug treatment protocols in malaria using a theoretical mathematical model, which gives an insight into potential effective treatment schemes. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biology

Exploring the benefits of antibody immune response in HIV-1 infection using a discrete model

S. P. Showa, F. Nyabadza, S. D. Hove-Musekwa, G. Magombedze

MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2016)

Article Multidisciplinary Sciences

Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis

Devyani Deshpande, Shashikant Srivastava, Moti Chapagain, Gesham Magombedze, Katherine R. Martin, Kayle N. Cirrincione, Pooi S. Lee, Thearith Koeuth, Keertan Dheda, Tawanda Gumbo

SCIENCE ADVANCES (2017)

Article Critical Care Medicine

Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis

Keertan Dheda, Laura Lenders, Gesham Magombedze, Shashikant Srivastava, Prithvi Raj, Erland Arning, Paula Ashcraft, Teodoro Bottiglieri, Helen Wainwright, Timothy Pennel, Anthony Linegar, Loven Moodley, Anil Pooran, Jotam G. Pasipanodya, Frederick A. Sirgel, Paul D. van Helden, Edward Wakeland, Robin M. Warren, Tawanda Gumbo

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Immunology

Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges

Gesham Magombedze, Jotam G. Pasipanodya, Shashikant Srivastava, Devyani Deshpande, Marianne E. Visser, Emmanuel Chigutsa, Helen McIlleron, Tawanda Gumbo

CLINICAL INFECTIOUS DISEASES (2018)

Article Immunology

Artificial intelligence-derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis

Jotam G. Pasipanodya, Wynand Smythe, Corinne S. Merle, Piero L. Olliaro, Devyani Deshpande, Gesham Magombedze, Helen McIlleron, Tawanda Gumbo

CLINICAL INFECTIOUS DISEASES (2018)

Article Immunology

Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!

Shashikant Srivastava, Devyani Deshpande, Gesham Magombedze, Tawanda Gumbo

CLINICAL INFECTIOUS DISEASES (2018)

Article Multidisciplinary Sciences

Inferring biomarkers for Mycobacterium avium subsp paratuberculosis infection and disease progression in cattle using experimental data

Gesham Magombedze, Tinevimbo Shiri, Shigetoshi Eda, Judy R. Stabel

SCIENTIFIC REPORTS (2017)

Article Biology

Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse

Gesham Magombedze, Jotam G. Pasipanodya, Tawanda Gumbo

Summary: The study proposes a new method combining mathematical modeling and machine learning to derive effective predictive biomarkers for tuberculosis long-term treatment outcomes. The new method demonstrated higher sensitivity and specificity compared to current methods, with a potential to accelerate evaluation of novel TB regimens and personalize therapy duration. These biomarkers have the potential to aid in better clinical trial designs and improve treatment outcomes in routine programs.

COMMUNICATIONS BIOLOGY (2021)

Article Microbiology

Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence

Jotam G. Pasipanodya, Deborah Ogbonna, Beatriz E. Ferro, Gesham Magombedze, Shashikant Srivastava, Devyani Deshpande, Tawanda Gumbo

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Article Microbiology

Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis

Shashikant Srivastava, Gesham Magombedze, Thearith Koeuth, Carleton Sherman, Jotam G. Pasipanodya, Prithvi Raj, Edward Wakeland, Devyani Deshpande, Tawanda Gumbo

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

No Data Available